Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Zimmer held back by federal probe; Intuitive, NuVasive revenues jump

This article was originally published in Clinica

Executive Summary

Developer of the Coblation soft tissue ablation technology ArthroCare has attributed significant increases in revenue and overall profit for its third-quarter results to the positive performance of its spine business. The Austin, Texas-based firm recorded product sales of $75.5m, aided by a 95% increase in spinal products, compared to the same period the previous year. Its spinal business now accounts for 15% of the company's overall sales and is largely driven by sales in its cavity products and the introduction of its new MD SpineWand soft tissue removal product to the market. ArthroCare claims that the positive performance in Q3 has set the company up to achieve it full year financial goals - it expects total revenue growth for the year to be at least 20%.

Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT050090

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel